Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001104659-26-035403

Options or other derivatives

  • CEO, President acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Mack Gene CEO, President 2026-03-24 Grant or award · Employee Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X06/tm269848-2_4seq1.xml…